Investors Hangout MVP's
Last Post: 05/13/2025 4:08:49 PM
Board Marks: 1059
Posts Today: 0
Board Views Today: 1927
11/02/2023 8:26:01 AM
11/02/2023 7:41:29 AM
11/02/2023 7:16:54 AM
11/01/2023 3:50:38 PM
11/01/2023 1:29:07 PM
11/01/2023 1:10:50 PM
11/01/2023 9:44:03 AM
11/01/2023 9:21:54 AM
11/01/2023 7:47:36 AM
10/31/2023 5:52:25 PM
10/31/2023 3:41:16 PM
10/31/2023 1:29:13 PM
10/31/2023 12:22:47 PM
10/31/2023 12:07:08 PM
10/31/2023 10:59:17 AM
10/31/2023 10:00:48 AM
10/31/2023 9:02:37 AM
10/31/2023 7:51:33 AM
10/30/2023 2:52:26 PM
10/30/2023 2:35:51 PM
10/30/2023 2:07:43 PM
10/30/2023 12:32:50 PM
10/30/2023 12:18:03 PM
10/30/2023 11:19:11 AM
10/30/2023 10:56:05 AM
10/30/2023 10:46:52 AM
10/30/2023 10:26:20 AM
10/30/2023 9:56:27 AM
10/30/2023 9:31:10 AM
10/30/2023 9:11:53 AM
10/30/2023 7:42:52 AM
10/29/2023 6:35:20 PM
10/27/2023 10:15:12 AM
10/27/2023 9:18:13 AM
10/27/2023 8:20:20 AM
10/27/2023 8:10:40 AM
10/27/2023 7:33:45 AM
10/27/2023 7:13:07 AM
10/27/2023 2:41:49 AM
10/26/2023 4:32:08 PM
10/26/2023 2:29:59 PM
10/26/2023 1:42:23 PM
10/26/2023 1:15:08 PM
10/26/2023 12:46:48 PM
10/26/2023 12:31:07 PM
10/26/2023 12:23:37 PM
10/26/2023 12:15:15 PM
10/26/2023 10:17:01 AM
10/26/2023 10:05:00 AM
10/26/2023 9:40:24 AM
Recent Articles
- Waterfall Network Launches Groundbreaking Tools for Web3 Innovation
- INE Security Enhances Cyber Defense Training with New Labs
- Pioneering Gene Therapy at Lurie Children's for Skin Disorders
- A Partnership for Growth: Glass House Brands and LEEF Team Up
- Strategic Partnership Between Glass House Brands and LEEF
- Avis Budget Group Announces Major $500 Million Notes Offering
- nCino Schedules Conference Call for First Quarter Results
- BioVie Announces Virtual Event for Parkinson's Treatment Discussion
- Stallion Uranium Faces Cease Trade Order and Future Plans
- Gain Therapeutics Highlights Progress and Financial Health in 2025
- PDS Biotech Expands Clinical Trials and Financial Overview
- Abeona Therapeutics Expands Access to Innovative Skin Disorder Treatment
- Quoin Pharmaceuticals Reports Encouraging Clinical Results for QRX003
- Engagement of Altimmune at Notable Investor Conferences Ahead
- Highland Copper Advances Copperwood Project with Engineering Efforts
- Promising Outcomes of REYOBIQ in Treating Leptomeningeal Metastases
- Creative Realities' Fiscal Q1 Report: Insights and Future Plans
- Anavex Life Sciences Prepares for Major Healthcare Events
- Pyxis Oncology Set for Key Investor Conferences Soon
- Bombardier's Strategic Move: New Notes Issuance to Manage Debt
- Pony AI's Founders Commit to Extended Lock-Ups to Strengthen Trust
- Emergent BioSolutions' Executive Participation in Key Conferences
- Advanced Flower Capital Inc. Reports Strong Q1 Performance 2025
- Arabsat and Telesat Join Forces for Revolutionary Connectivity
- SolaXCloud's Cybersecurity Strategy to Comply with NIS2
- Partnering in Angola: Sintana Energy and Corcel plc's Vision
- Technology and Public Welfare: Huabochuangke's Vision Unveiled
- MediPharm Labs Reaches Key Milestones with Q1 2025 Performance
- DeFi Technologies Reports Stellar Q1 2025 Financial Results
- Mountain Province Diamonds Secures CAD$33 Million Funding Boost
- Rupali Sawhney Takes Lead as Chief Customer Officer at Otelier
- Federal Realty Investment Trust Sells Levare Apartments for $74M
- Palatin Technologies Reports Impressive Q3 2025 Results
- Maury Donnelly & Parr: A Legacy of Service for 150 Years
- Aspen Aerogels to Showcase Innovations at Annual Investor Event
- Metrika and S&P Global Ratings Innovate Digital Asset Risk Insights
- TCL Achieves Global Design Excellence with 17 Awards
- Easy Street Capital Enhances Financing Access for Investors
- The Impact of Pets on Community Health and Well-Being
- Insights from Callan on 2025 Defined Contribution Trends
- Funding for Housing Stability: A Major Grant Impacting Lives
- PussFi Unveils $PUSS: A Memetic Token with Genuine Utility
- Charlotte's Web Sees Promising Growth in Q1 Results for 2025
- Innovative Collaboration Drives Cancer Education and Research Forward
- Unveiling Speaker Line-up for M360 Eurasia in 2025
- Innovative Advances in Gene Therapy for Methylmalonic Acidemia
- Explore the Cutting-Edge Speakers at GSMA M360 Eurasia 2025
- Local Bounti Records Impressive Growth in Q1 Financials
- Unicycive Therapeutics Reports Strong Financial Performance
- Draganfly Welcomes Peter Lambrinakos to Public Safety Board
